FDA NDC Directory · JSON-LD · Markdown

Naloxone Hydrochloride

NDC 70385-2033 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSina Health Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA207633
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsNALOXONE HYDROCHLORIDE (.4 mg/mL)
Marketing started20170808
Package count1

External sources

Source: openFDA. Public-domain (CC0).